The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary or medically reversible adverse health consequences." However, the classification is also used "where the probability of serious adverse health consequences is remote."

The Food and Drug Administration (FDA) has been busy lately with various recalls. One involved Power Stick deodorant and another involved various ice cream bars across 23 states. Now, a new recall was announced on Monday by the FDA,

Taking medication for an allergic reaction? You might face severely itchy skin as a side effect of Zyrtec or Xyzal, according to a recent FDA warning for long-term users. Here's what you need to know.

An influx of illegal vapes that are appealing to children has been making its way into the U.S. from China, the head of the FDA warned in an interview with ABC News.

FDA Commissioner Dr. Marty Makary joins Morning Joe to address the agency’s controversial decision to keep Juul e-cigarettes on the market, ongoing reviews of mifepristone, and the latest efforts on women's health and vaccine guidance.

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat menopause. The 12-person panel encouraged the use of the

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational gene therapy trials for limb girdle muscular dystrophy following three patient deaths potentially linked to the company's treatments.

As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school shootings. He even proposed sending people who take them to “wellness farms,” where they can grow their own organic foods, get “re-parented,” and wean themselves off antidepressants and other medications.

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of the Center for Drug Evaluation and Research.

This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which received FDA clearance earlier this month

Replimune stock (ticker: REPL) cratered on Tuesday after the biotech said the U.S. Food and Drug Administration rejected an application seeking approval of its experimental skin cancer treatment.